drugset / Trial / NCT04899674
A Study in Healthy Men and Women to Test Whether BI 1358894 Influences the Amount of Bupropion in the Blood
NaSingle-groupOpen-labelTreatment
Summary
The main objective of this trial is to investigate the relative bioavailability of a single dose of bupropion when given alone (Reference) compared with co-administration (Test) with BI 1358894 in healthy volunteers.
Timeline
- Start
- 2021-06-30
- Primary completion
- 2021-09-02
- Completion
- 2021-09-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1358894 | Small molecule | — | — |
| Subject | Bupropion | Small molecule | — | — |
Indications
No indication recorded.